• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低剂量肝素和双氢麦角胺对创伤后髋关节手术患者术后深静脉血栓形成发生率的影响。

Effect of low-dose heparin and dihydroergotamine on frequency of postoperative deep-vein thrombosis in patients undergoing post-traumatic hip surgery.

作者信息

Lahnborg G

出版信息

Acta Chir Scand. 1980;146(5):319-22.

PMID:7468062
Abstract

The effect of low doses of heparin (5000 units of sodium heparin every 12 hours for 10 days) and dihydroergotamine (DHE) (0.5 mg at the same intervals as heparin) on the incidence of deep-vein thrombosis (D.V.T.) in the legs was studied on 210 patients undergoing nailing of a fractured neck of the femur. The patients were allocated randomly to receive heparin (70 patients) or heparin + dihydroergotamine (71 patients) or saline (69 patients, acting as controls). D.V.T. developed in 15 patients in the heparin group, in 12 patients in heparin + DHE group and in 28 patients in the control group. There is a significant difference between the two groups receiving heparin on the one hand and the control group on the other. DHE does not seem to reduce the incidence of D.V.T. any further in this group of patients.

摘要

对210例接受股骨颈骨折穿钉术的患者,研究了低剂量肝素(每12小时5000单位肝素钠,共10天)和双氢麦角胺(DHE)(与肝素相同间隔给予0.5毫克)对腿部深静脉血栓形成(D.V.T.)发生率的影响。患者被随机分配接受肝素治疗(70例)或肝素+双氢麦角胺治疗(71例)或生理盐水治疗(69例,作为对照)。肝素组有15例发生D.V.T.,肝素+DHE组有12例发生D.V.T.,对照组有28例发生D.V.T.。一方面接受肝素治疗的两组与另一方面的对照组之间存在显著差异。在该组患者中,双氢麦角胺似乎并未进一步降低D.V.T.的发生率。

相似文献

1
Effect of low-dose heparin and dihydroergotamine on frequency of postoperative deep-vein thrombosis in patients undergoing post-traumatic hip surgery.低剂量肝素和双氢麦角胺对创伤后髋关节手术患者术后深静脉血栓形成发生率的影响。
Acta Chir Scand. 1980;146(5):319-22.
2
Prevention of postoperative deep vein thrombosis by a combination of subcutaneous heparin with subcutaneous dihydroergotamine or oral sulphinpyrazone.皮下注射肝素联合皮下注射双氢麦角胺或口服磺吡酮预防术后深静脉血栓形成
Thromb Haemost. 1985 Oct 30;54(3):570-3.
3
The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.依诺肝素在髋膝关节手术中预防深静脉血栓形成的效果——与双氢麦角胺-肝素联合用药的比较
Ann Chir Gynaecol. 1996;85(4):359-63.
4
Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine.每日注射一次低分子量肝素和双氢麦角胺预防术后深静脉血栓形成。
Vasa. 1989;18(2):152-6.
5
Prophylaxis of deep vein thrombosis after major abdominal surgery. Comparison between dihydroergotamine-heparin and intermittent pneumatic calf compression and evaluation of added graduated static compression.腹部大手术后深静脉血栓形成的预防。双氢麦角胺-肝素与间歇性小腿充气加压的比较及附加分级静态加压的评估
Acta Chir Scand. 1986 Oct;152:597-600.
6
Prevention of postoperative thromboembolisms in general surgery by the combination of heparin and dihydroergotamine.肝素与双氢麦角胺联合预防普通外科手术后血栓栓塞
Acta Chir Hung. 1986;27(2):107-14.
7
Mechanical versus pharmacologic prevention of deep venous thrombosis.
Surg Gynecol Obstet. 1981 Apr;152(4):448-50.
8
[Optimation of postoperative prophylaxis of thrombosis in gynaecology (author's transl)].
Geburtshilfe Frauenheilkd. 1978 Feb;38(2):98-104.
9
Low-dose heparin and deep-vein thrombosis after total hip replacement.
Thromb Haemost. 1976 Aug 31;36(1):157-64.
10
United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.美国关于双氢麦角胺与肝素预防深静脉血栓形成的试验。
Am J Surg. 1985 Oct 8;150(4A):25-32.

引用本文的文献

1
Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures.肝素、低分子量肝素及预防髋部骨折手术后深静脉血栓形成和肺栓塞的物理方法。
Cochrane Database Syst Rev. 2000;2002(2):CD000305. doi: 10.1002/14651858.CD000305.
2
Rational antithrombotic therapy and prophylaxis in elderly, immobile patients.老年行动不便患者的合理抗栓治疗与预防
Drugs Aging. 1998 Aug;13(2):145-57. doi: 10.2165/00002512-199813020-00006.
3
Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients.
年龄导致的生理变化。对老年患者血栓形成的预防和治疗的影响。
Drugs Aging. 1994 Jul;5(1):20-33. doi: 10.2165/00002512-199405010-00003.
4
[Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?].
Langenbecks Arch Chir. 1983;360(2):81-95. doi: 10.1007/BF01254917.
5
[Thrombosis prevention with heparin/dihydroergotamine versus heparin/Sintrom in Ender nailing of pertrochanteric fractures].[肝素/双氢麦角胺与肝素/新抗凝剂在股骨转子间骨折髓内钉固定术中预防血栓形成的比较]
Unfallchirurgie. 1988 Feb;14(1):12-21.
6
Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine.髋部骨折患者血栓栓塞的预防。低剂量肝素与低分子量肝素联合双氢麦角胺的比较。
Arch Orthop Trauma Surg. 1989;108(1):10-3. doi: 10.1007/BF00934150.
7
[Prevention of thromboembolism in para-articular femoral fractures of the hip--results of a prospective randomized study of heparin-DHE and ASS-DHE].[髋部关节周围股骨骨折中血栓栓塞的预防——肝素-二氢麦角碱和阿司匹林-二氢麦角碱前瞻性随机研究的结果]
Unfallchirurgie. 1990 Jun;16(3):128-38. doi: 10.1007/BF02588009.
8
[Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement].[两种低分子量肝素制剂在择期髋关节置换患者中的不同疗效]
Langenbecks Arch Chir. 1991;376(3):147-51. doi: 10.1007/BF00250339.
9
Prevention of deep vein thrombosis in patients with hip fractures: low molecular weight heparin versus dextran.
World J Surg. 1992 Sep-Oct;16(5):980-4; discussion 984-5. doi: 10.1007/BF02067011.